To view this email as a web page, click here.
 
PHARMACISTS' REPORT
 
Community Pharmacists: An Untapped Resource for a Little-Known Problem
Anti-fungal resistance hasn't gotten much attention — but it's a big problem.
Read more
 
Edaravone (Radicava) for ALS
Edaravone has been approved for patients with amyotropic lateral sclerosis.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.